Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
We Can Medicines CoROCO:6929 -0.45%46 FCF Margin % is 8.75% as of Dec. 2025, which is 76% above its 10-year median of 4.98. GuruFocus rates ROCO:6929 with a GF Score™ of 46/100 and a GF Value™ of NT$40.73 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,957 Consumer Packaged Goods companies, We Can Medicines Co ranks better than 68.37% on this metric.
The historical rank and industry rank for We Can Medicines Co's FCF Margin % or its related term are showing as below:
ROCO:6929'
s FCF Margin % Range Over the Past 10 Years
Min: 0.68 Med: 4.98 Max: 6.77
Current: 6.33
During the past 6 years, the highest FCF Margin % of We Can Medicines Co was 6.77%. The lowest was 0.68%. And the median was 4.98%.
ROCO:6929's FCF Margin % is ranked better than 68.37% of 1957
companies
in the Consumer Packaged Goods industry
Industry Median: 2.11
vs ROCO:6929: 6.33
We Can Medicines Co FCF Margin % Related Terms
We Can Medicines Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for We Can Medicines Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, We Can Medicines Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
We Can Medicines Co FCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where We Can Medicines Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
We Can Medicines Co (ROCO:6929) has a FCF Margin % of 8.75% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on We Can Medicines Co and its competitors. This is 76% above median its historical median of 4.98. Over the past decade, We Can Medicines Co's FCF Margin % has ranged from 0.68 to 6.77. According to the industry distribution chart, We Can Medicines Co ranks #619 out of 1957 companies in the Consumer Packaged Goods industry, placing it in the top 31.6%.
Is We Can Medicines Co's FCF Margin % too high?
We Can Medicines Co's current FCF Margin % of 8.75% is 76% above median its 10-year median of 4.98. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 6.77. The Consumer Packaged Goods industry median FCF Margin % is 2.11. We Can Medicines Co's value of 8.75% is 314.7% above this industry median. Based on the distribution chart, We Can Medicines Co ranks #619 out of 1957 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, We Can Medicines Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does We Can Medicines Co's FCF Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, We Can Medicines Co ranks #619 out of 1957 companies for FCF Margin %. This puts We Can Medicines Co in the upper half of its industry. The industry median FCF Margin % is 2.11. We Can Medicines Co's value of 8.75% is 314.7% above this benchmark. Historically, We Can Medicines Co's own FCF Margin % has ranged from 0.68 to 6.77 over the past decade. While the company's 10-year median is 4.98 vs. the industry median of 2.11, We Can Medicines Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Consumer Packaged Goods company?
The median FCF Margin % among Consumer Packaged Goods companies is 2.11, based on 1,957 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. We Can Medicines Co's current FCF Margin % of 8.75% is 314.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on We Can Medicines Co and its competitors. For the Consumer Packaged Goods industry, the median FCF Margin % is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. We Can Medicines Co's current FCF Margin % is 8.75%, which is 76% above median its own 10-year median of 4.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is We Can Medicines Co stock overvalued right now?
Based on GuruFocus' analysis, We Can Medicines Co (ROCO:6929) is currently considered Possible Value Trap. The stock's GF Value™ is NT$40.73, compared to a current price of NT$22.30 — trading 45.2% below its estimated fair value. The current FCF Margin % is 8.75%, which is 76% above median its 10-year median of 4.98 and 314.7% above the Consumer Packaged Goods industry median of 2.11. We Can Medicines Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For We Can Medicines Co (ROCO:6929), the current FCF Margin % is 8.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is We Can Medicines Co (ROCO:6929) Overvalued in 2026?
Based on GuruFocus' analysis, We Can Medicines Co stock appears to be undervalued.
The current stock price of NT$22.30 is trading 45.2% below its estimated GF Value™ of NT$40.73.
GuruFocus considers We Can Medicines Co to be Possible Value Trap.
Key valuation signals for ROCO:6929:
FCF Margin %: 8.75% (76% above median its 10-year median of 4.98)
GF Value™: NT$40.73 vs. price of NT$22.30 (45.2% below fair value)
Industry Position: 314.7% above the Consumer Packaged Goods median (#619 of 1957)
No single metric tells the full story. See the ROCO:6929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
46GF Score
Get the complete analysis for ROCO:6929
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6929 has been successfully added to your 
